Do we need a femoral artery route for transvenous PDA closure in children with ADO-I?
- PMID: 25333978
- PMCID: PMC5337062
- DOI: 10.5152/akd.2014.5269
Do we need a femoral artery route for transvenous PDA closure in children with ADO-I?
Abstract
Objective: The standard procedure in percutaneous closure of patent ductus arteriosus (PDA) with Amplatzer duct occluder-I (ADO-I) is transvenous closure guided by aortic access through femoral artery. The current study aims to compare the procedures for PDA closure with ADO-I: only transvenous access with the standard procedure.
Methods: This study was designed retrospectively and 101 pediatric patients were included. PDA closure was done by only femoral venous access in 19 of them (group 1), arterial and venous access used in 92 patients (group 2) between 2004 to 2012 years. The position of the device and residual shunt in group1 was evaluated by the guidance of the aortogram obtained during the return phase of the pulmonary artery injection and guidance of transthoracic echocardiography. Shapiro-Wilk's test, Mann-Whitney U, chi-squared tests were used for statistical comparison.
Results: The procedure was successful in 18 (95%) patients in group 1 and 90 (98%) patients in group 2. Complications including the pulmonary artery embolization (n=1), protrusion to pulmonary artery (n=1), inguinal hematoma (n=3), bleeding (n=2) were only detected in group 2. In other words, while complications were observed in 7 (7.2%) patients in group 2, no minor/major complication was observed in group 1. Complete closure in group 1 was: in catheterization room 14 (77.8%), at 24th hour in 2 (11.1%), at first month in 2 (11.1%). Complete closure in group 2 was: 66 (73.4%) patients in the catheterization room, 21 (23.3%) at 24th hour, 3 (3.3%) at first month, complete closure occurred at the end of first month.
Conclusion: In percutaneouse PDA closure via ADO-I, this technique can be a choice for patients whose femoral artery could not be accessed, or access is impossible/contraindicated. But for the reliability and validity of this method, randomized multicenter clinical studies are necessary.
Conflict of interest statement
Figures

Comment in
-
Do we need a femoral artery route for transvenous PDA closure in children with ADO I?Anatol J Cardiol. 2015 Mar;15(3):248. doi: 10.5152/akd.2015.14638. Anatol J Cardiol. 2015. PMID: 25880177 Free PMC article. No abstract available.
References
-
- Porstmann W, Wierny L, Warnke H. Closure of persistent ductus arteriosus without thoracotomy. Ger Med Mon. 1967;12:259–61. - PubMed
-
- Faella HJ, Hijazi ZM. Closure of the patent ductus arteriosus with the amplatzer PDA device: immediate results of the international clinical trial. Catheter Cardiovasc Interv. 2000;51:50–4. [CrossRef] - PubMed
-
- Ghasemi A, Pandya S, Reddy SV, Turner DR, Du W, Navabi MA, et al. Trans-catheter closure of patent ductus arteriosus-What is the best device? Catheter Cardiovasc Interv. 2010;76:687–95. [CrossRef] - PubMed
-
- Ammar RI, Hegazy RA. Percutaneous closure of medium and large PDAs using amplatzer duct occluder (ADO) I and II in infants: safety and efficacy. J Invasive Cardiol. 2012;24:579–82. - PubMed
-
- Pag FA, Polat TB, Oflaz MB, Balli Ş. Closure of patent ductus arteriosus with duct occluder device in adult patients: evaluation of the approaches to facilitate the procedure. Anatol J Cardiol. 2011;11:64–70. [CrossRef] - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources